Goldenwell Biotech, Inc. — Cash Flow Charts
8 quarters of history · ending 2025-09-30 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+224.4% +$107K
$59K
Free Cash Flow↑+224.4% +$107K
$59K
Financing Cash Flow↓-100.0% -$2K
$0
Debt Issued↑+600.0% +$60K
$70K